OS Therapies Incorporated
Price
FilingsNewest: 8-K, Material agreementOct 5 →InsidersNo open-market buys or sales.→HoldersVanguard 1.7%CM 0.9%Geode 0.7%→Financing →PeersClosest companies: AKTX, CMPX, INDP→
From the filings
Figures
- Net income
- −$39.4Mlast 12 months
- Operating cash flow
- −$15.4Mlast 12 months
- Cash and equivalents
- $205,035at the last balance sheet
- Shares outstanding
- 45.3M shareson issue